MedTrace Logo

Evaluation of an Information Pamphlet for Postpartum Women That Had a Hypertensive Pregnancy

NCT02523781 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2021-04-27

No results posted yet for this study

Summary

It is known that preeclampsia is a risk factor for cardiovascular diseases, diabetes, chronic hypertension, nephropathy and thromboembolism. The study's aim, subsequent to these informations, is to help prevent those consequences. Information tools have been known to enhance retention of information given orally. The objective of this study is to assess the knowledge and satisfaction of women after an episode of preeclampsia after reading an explanatory pamphlet on preeclampsia. The investigators also want to change their perception on cardiovascular risk, their risk of recurrence and preeclampsia's medium to long-term consequences and the ways to prevent them.

Conditions

  • Hypertension, Pregnancy-Induced

Interventions

OTHER

information pamphlet

The intervention group receives the information pamphlet

Sponsors & Collaborators

  • Université de Sherbrooke

    lead OTHER

Principal Investigators

  • Sauvé Nadine, MD · Université de Sherbrooke

  • Anne-Marie côté, MD · Université de Sherbrooke

  • Annabelle Cumyn, MD · Université de Sherbrooke

  • Marie-Eve Roy-Lacroix, MD · Université de Sherbrooke

  • Myriam Champagne, MD · Université de Sherbrooke

  • Marie-Hélène Pesant, MD · Université de Sherbrooke

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2017-08-20
Completion
2020-07-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02523781 on ClinicalTrials.gov